142 related articles for article (PubMed ID: 2291381)
21. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
22. Venous thrombosis associated with lupus anticoagulant and anticardiolipin antibodies.
Pelkonen P; Simell O; Rasi V; Vaarala O
Acta Paediatr Scand; 1988 Sep; 77(5):767-72. PubMed ID: 3144118
[TBL] [Abstract][Full Text] [Related]
23. Antiphospholipid antibodies in the connective tissue diseases: their relation to the antiphospholipid syndrome and forme fruste disease.
Buchanan RR; Wardlaw JR; Riglar AG; Littlejohn GO; Miller MH
J Rheumatol; 1989 Jun; 16(6):757-61. PubMed ID: 2778757
[TBL] [Abstract][Full Text] [Related]
24. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
[TBL] [Abstract][Full Text] [Related]
25. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome.
Lopez LR; Dier KJ; Lopez D; Merrill JT; Fink CA
Am J Clin Pathol; 2004 Jan; 121(1):142-9. PubMed ID: 14750252
[TBL] [Abstract][Full Text] [Related]
26. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C
Lupus; 2007; 16(10):810-6. PubMed ID: 17895304
[TBL] [Abstract][Full Text] [Related]
27. [Incidence of selected antiphospholipid antibodies in a group of patients with systemic lupus erythematosus].
Fojtík Z; Beránek M; Klabusay M; Korístek Z; Buliková A
Vnitr Lek; 2004 Apr; 50(4):267-73. PubMed ID: 15214295
[TBL] [Abstract][Full Text] [Related]
28. Factor V Leiden, antiphospholipid antibodies and thrombosis in systemic lupus erythematosus.
Fijnheer R; Horbach DA; Donders RC; Vilé H; von Oort E; Nieuwenhuis HK; Gmelig-Meijling FH; de Groot PG; Derksen RH
Thromb Haemost; 1996 Oct; 76(4):514-7. PubMed ID: 8902988
[TBL] [Abstract][Full Text] [Related]
29. [Antiphospholipid syndrome and cardiovascular disease].
García Bolao JI; Iglesias I; Fidalgo ML; Alegría E; Mejía S; Huelmos A; Garrote C
Rev Med Univ Navarra; 1990; 34(3):151-5. PubMed ID: 2101494
[TBL] [Abstract][Full Text] [Related]
30. Anticardiolipin syndrome in childhood: a report of two cases.
Ravelli A; Caporali R; Bianchi E; Viola S; Solmi M; Montecucco C; Martini A
Clin Exp Rheumatol; 1990; 8(1):95-8. PubMed ID: 2112074
[TBL] [Abstract][Full Text] [Related]
31. [Antiphospholipid antibodies in systemic lupus erythematosus: incidence, significance and relation to lupus nephritis].
Zea Mendoza A; Rodríguez García A; Irigoyen Oyarzábal MV; Vázquez Díaz M; Pardo Vigo A; Mampaso FM; Ortuño Mirete J
Med Clin (Barc); 1989 May; 92(19):724-8. PubMed ID: 2502695
[TBL] [Abstract][Full Text] [Related]
32. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N
Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
[TBL] [Abstract][Full Text] [Related]
33. [Anticardiolipin antibodies in patients with systemic lupus erythematosus].
Petrović R; Petrović M; Novicić-Sasić D; Damjanov N
Srp Arh Celok Lek; 1994; 122 Suppl 1():98-100. PubMed ID: 18173204
[TBL] [Abstract][Full Text] [Related]
34. Anti-beta 2-glycoprotein I antibodies of IgM class are linked to thrombotic disorders in young women without autoimmune disease.
Salobir B; Sabovic M; Hojnik M; Cucnik S; Kveder T
Immunobiology; 2007; 212(3):193-9. PubMed ID: 17412286
[TBL] [Abstract][Full Text] [Related]
35. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies.
Horbach DA; van Oort E; Donders RC; Derksen RH; de Groot PG
Thromb Haemost; 1996 Dec; 76(6):916-24. PubMed ID: 8972011
[TBL] [Abstract][Full Text] [Related]
36. The "primary" antiphospholipid syndrome: major clinical and serological features.
Asherson RA; Khamashta MA; Ordi-Ros J; Derksen RH; Machin SJ; Barquinero J; Outt HH; Harris EN; Vilardell-Torres M; Hughes GR
Medicine (Baltimore); 1989 Nov; 68(6):366-74. PubMed ID: 2509856
[TBL] [Abstract][Full Text] [Related]
37. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
Swadzba J; De Clerck LS; Stevens WJ; Bridts CH; van Cotthem KA; Musial J; Jankowski M; Szczeklik A
J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792
[TBL] [Abstract][Full Text] [Related]
38. Small vessel thrombosis without major thrombotic events in systemic lupus erythematosus patients with antiphospholipid syndrome.
Sipek-Dolnicar A; Hojnik M; Rozman B; Vizjak A; Ferluga D
Wien Klin Wochenschr; 2000 Aug; 112(15-16):707-10. PubMed ID: 11020961
[TBL] [Abstract][Full Text] [Related]
39. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus.
Harris EN; Gharavi AE; Boey ML; Patel BM; Mackworth-Young CG; Loizou S; Hughes GR
Lancet; 1983 Nov; 2(8361):1211-4. PubMed ID: 6139567
[TBL] [Abstract][Full Text] [Related]
40. [Prevalence of thrombosis in secondary antiphospholipid-protein syndrome].
Swadźba J; Musiał J; Jankowski M; Grzywacz M; Szczeklik A
Pol Merkur Lekarski; 1996 Nov; 1(5):310-2. PubMed ID: 9273202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
